Open Access
Analytical validation of GMEX rapid point-of-care CYP2C19 genotyping system for the CHANCE-2 trial
Xia Meng, Anxin Wang, Guojun Zhang, Siying Niu, Wei Li, Sifei Han, Fang Fang, Xingquan Zhao, Kehui Dong, Zening Jin, Huaguang Zheng, Kelin Chen, Hao Li, Chengyuan Yang, Yongjun Wang
DOI: 10.1136/svn-2021-000874 Published 28 June 2021
Xia Meng
1
China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
2
Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
Anxin Wang
1
China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
2
Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
Guojun Zhang
3
Department of Clinical Diagnosis Laboratory, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
Siying Niu
1
China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
2
Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
Wei Li
1
China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
2
Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
Sifei Han
4
Biomedical and Health Informatics, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA
Fang Fang
1
China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
2
Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
Xingquan Zhao
1
China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
2
Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
Kehui Dong
1
China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
2
Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
Zening Jin
5
Department of Cardiology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
Huaguang Zheng
1
China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
2
Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
Kelin Chen
3
Department of Clinical Diagnosis Laboratory, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
Hao Li
1
China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
2
Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
Chengyuan Yang
1
China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
2
Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
Yongjun Wang
1
China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
2
Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China

Submit a Response to This Article
No eLetters have been published for this article.
Analytical validation of GMEX rapid point-of-care CYP2C19 genotyping system for the CHANCE-2 trial
Xia Meng, Anxin Wang, Guojun Zhang, Siying Niu, Wei Li, Sifei Han, Fang Fang, Xingquan Zhao, Kehui Dong, Zening Jin, Huaguang Zheng, Kelin Chen, Hao Li, Chengyuan Yang, Yongjun Wang
Stroke and Vascular Neurology Jun 2021, 6 (2) 274-279; DOI: 10.1136/svn-2021-000874

Analytical validation of GMEX rapid point-of-care CYP2C19 genotyping system for the CHANCE-2 trial
Xia Meng, Anxin Wang, Guojun Zhang, Siying Niu, Wei Li, Sifei Han, Fang Fang, Xingquan Zhao, Kehui Dong, Zening Jin, Huaguang Zheng, Kelin Chen, Hao Li, Chengyuan Yang, Yongjun Wang
Stroke and Vascular Neurology Jun 2021, 6 (2) 274-279; DOI: 10.1136/svn-2021-000874
Analytical validation of GMEX rapid point-of-care CYP2C19 genotyping system for the CHANCE-2 trial
Xia Meng, Anxin Wang, Guojun Zhang, Siying Niu, Wei Li, Sifei Han, Fang Fang, Xingquan Zhao, Kehui Dong, Zening Jin, Huaguang Zheng, Kelin Chen, Hao Li, Chengyuan Yang, Yongjun Wang
Stroke and Vascular Neurology Jun 2021, 6 (2) 274-279; DOI: 10.1136/svn-2021-000874